CMT
CMT (Compliance Meds Technologies, LLC) is a privately-held Miami-based digital health company that builds the CleverCap cellular smart pill-bottle platform for real-time medication adherence monitoring. Founded in 2011, it serves pharmaceutical manufacturers, health plans, specialty pharmacies, and care providers across 25+ countries and 300+ sites.
- Company typePrivate
- Founded2011
- HeadquartersMiami, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What CMT does
CMT (Compliance Meds Technologies, LLC) is a privately-held digital health technology company founded in 2011 and headquartered in Miami, Florida. The company develops the CleverCap platform — a hardware-plus-software medication adherence system in which a cellular-connected (3G) smart cap attaches to standard medication vials and records dosing events, generates audio/visual reminders, and transmits data in real time to a cloud-based reporting and analytics portal. The product family consists of CleverCap PRO, which detects individual pill dispensing and controls dose timing, and CleverCap LITE, which monitors vial or bottle access. A companion Companion mobile app and an Insights & Analytics Portal wrap the hardware for patient engagement and stakeholder reporting.
The company sells to pharmaceutical manufacturers (across brand management, R&D, and market access functions), health plans, specialty pharmacies, and care management organizations such as addiction treatment centers. Distribution occurs through enterprise contracts, pharmacy incorporation into dispensed vials, direct patient shipment, clinical trial deployment, and provider channels. Revenue is generated on a subscription/recurring basis combining hardware deployment with ongoing software and data services; pricing is quote-based and not publicly disclosed. Named enterprise deployments include Abbott (Colombia emerging-markets rollout), Merck (clinical drug development), Recovery Centers of America and California Highlands (addiction and mental health treatment), and EnvoyHealth/Diplomat (specialty pharmacy). The company also integrates with Oracle Health Sciences' mHealth Connector Cloud Service for clinical trial eClinical data flows.
CMT operates as a founder-led organization under CEO Moses Zonana with 1–10 employees, supplemented by an advisory board of senior pharmaceutical and healthcare executives including former leaders from Pfizer, Johnson & Johnson, United Healthcare, CVS Caremark, Impax Laboratories, and Blue Cross Blue Shield. Reported scale metrics include deployment in 25+ countries, 300+ sites, 1M+ dosing events recorded, an average 95% adherence rate with CleverCap PRO, a 20%+ adherence lift, and 4.8/5 patient satisfaction. The company has received industry recognition from Frost & Sullivan (2013 North American New Product Innovation Award for Medication Compliance) and URAC (2013 Best Practice in Health Care Consumer Engagement and Protection). No funding rounds, revenue figures, or M&A activity are disclosed in the available data.
CMT firmographics
Firmographics- Name
- CMT
- Legal name
- Compliance Meds Technologies, LLC
- Website
- https://cmtcares.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CMT (Compliance Meds Technologies, LLC) is a privately-held Miami-based digital health company that builds the CleverCap cellular smart pill-bottle platform for real-time medication adherence monitoring. Founded in 2011, it serves pharmaceutical manufacturers, health plans, specialty pharmacies, and care providers across 25+ countries and 300+ sites.
- Ownership category
- akta.pro rank
CMT industry classification
Industry- Product category
- Medical Devices (Medication Adherence Technology)
- NAICS
- Software Publishers (5132)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
Keywords
Where CMT is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CMT business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Device Sales and Software Services: CMT generates revenue through the sale and deployment of CleverCap devices (PRO and LITE) along with associated software services including the Companion App and cloud-based reporting/analytics portal. The platform is provided to pharmaceutical manufacturers, health plans, employers, pharmacies, care management organizations and patients.
- Enterprise Software Platform: Tailored medication management tools provided to various settings including senior care, addiction treatment, and clinical trials, with technology deployment through pharmacy incorporation into existing medication vials/bottles, direct patient shipping, or distribution through participating doctors.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
CMT product offering
Product offeringCore offering
CMT designs, manufactures, and sells the CleverCap family of cellular-connected smart pill bottle caps (CleverCap PRO and CleverCap LITE) that capture real-time medication dosing events and transmit them to a cloud-based analytics portal and companion mobile app. The integrated platform is offered to pharmaceutical manufacturers, health plans, pharmacies, and clinical trial sponsors to improve medication adherence, generate real-world evidence, and support patient engagement across chronic, specialty, and addiction-treatment therapies.
Product overview
CMT offers a platform-plus-modules architecture centered on the CleverCap smart pill bottle device family. The core products are CleverCap PRO and CleverCap LITE, which attach to standard medication vials and provide medication adherence tracking with automated alerts. These devices connect to the Insights & Analytics Portal (secure cloud-based reporting/analytics system) and the Companion App (mobile application for patient engagement). Together, the platform delivers real-time medication monitoring, dose control, patient reminders, and analytics to pharma companies, healthcare providers, and patients.
Differentiator
Problem solved
Functional benefit
Brands
- CleverCap: Smart pill bottle/cap technology that tracks medication adherence, provides alerts, and transmits dosing data via cellular networks. Includes CleverCap PRO (individual pill-level tracking and dose control) and CleverCap LITE (vial access tracking).
- CleverCap LITE
- CleverCap PRO
- Companion App
- Insights & Analytics Portal
- CMT Medication Management Platform
Products and services
- CleverCap PRO Advanced cellular-connected smart pill bottle cap that detects when an individual pill is dispensed and controls dosage timing so patients receive the right dose at the right time. Includes audio and visual reminders, tamper-proofing, and automatic data transmission to the analytics portal, achieving reported 95% average regimen adherence.
- CleverCap LITE Cellular-connected smart pill bottle cap that tracks when the vial or bottle is accessed or not properly reclosed, adding a layer of security and reminder capability without individual pill-level granularity. Reported 96% regimen adherence.
- Companion App Mobile application that pairs with CleverCap devices to help patients track and improve medication dosing habits, showing which medicines to take, which were missed, and providing reminders via phone notifications.
- Insights & Analytics Portal Secure, cloud-based reporting and analytics portal that receives real-time medication adherence data from CleverCap devices and delivers actionable patient insights, engagement tools, and analytics dashboards for healthcare providers, payers, and pharmaceutical companies.
- CMT Medication Management Platform Integrated enterprise digital health platform combining CleverCap smart adherence devices, Companion App, and Insights & Analytics Portal to connect patients, prescribing physicians, and dispensing pharmacies for improved medication compliance, deployed across 25+ countries and 300+ sites.
Quantifiable outcome
- 95% average adherence rate with CleverCap PRO; 96% with CleverCap LITE
- +4 more outcomes
Companies that use CMT
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles4 records
CMT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability1 record
Feature5 records
CMT partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, minor and flagship.
- MerckcoreMerck is leveraging CMT's CleverCap technology in clinical drug development programs to improve medication adherence during clinical trials, enabling better trial data quality and patient outcomes.
- Diplomat (EnvoyHealth)minorEnvoyHealth, a specialty pharmacy subsidiary of Diplomat, piloted CMT's adherence technology program to improve patient outcomes through medication management technology.
- Recovery Centers of AmericaminorRecovery Centers of America and California Highlands use CMT technology to increase successful patient outcomes and reduce costs for addiction and mental health treatment programs.
- Oracle Health SciencescoreOracle Health Sciences is integrating CMT's CleverCap into their mHealth Connector Cloud Service, enabling seamless real-time display of dosing patterns data into eClinical systems used by clinical trial sites and clinical teams. This partnership allows CMT to participate in Oracle's ecosystem for digital clinical trials at scale.
- AbbottflagshipAbbott uses CleverCap technology in Colombia as part of their emerging markets pharmaceutical strategy. The technology fits on standard pill bottles, alerts patients to take medication, dispenses prescribed doses, and provides internet connectivity for doctors to monitor patient compliance.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
CMT competitors and assessment
Company assessmentDirect peers
- AdhereTech: AdhereTech builds connected smart pill bottles that record dose-level adherence and transmit data to caregivers and providers. It is the closest direct competitor to CMT's CleverCap PRO on hardware-based, cellular-connected adherence monitoring for chronic and specialty medications.
- Propeller Health (ResMed): Propeller Health, acquired by ResMed, attaches sensors to inhalers to track and improve adherence for asthma and COPD. It is a direct functional analog of CMT's CleverCap platform applied to inhaled therapies and serves the same pharmaceutical adherence and clinical-trial use cases.
- etectRx: etectRx makes the ID-Cap system, an ingestible sensor embedded in a capsule that confirms ingestion via a wearable patch. It targets the same clinical-trial and specialty pharma use cases as CleverCap, competing for digital adherence endpoints in pharma R&D and value-based care contracts.
- Medisafe: Medisafe is a leading digital medication adherence platform combining a patient-facing app, caregiver dashboards, and pharma-sponsored programs. It overlaps directly with CMT's Companion App and Insights & Analytics Portal for chronic-condition adherence, although Medisafe is app-first versus CMT's hardware-first model.
Broad incumbents
- Aptar Pharma: Aptar Pharma is a global leader in drug delivery devices, including connected dispensers and digital health solutions for pharma. As a much larger incumbent, it is a comparable adjacent player for pharma-grade adherence hardware that CMT's CleverCap competes with for OEM/whitelabel deals.
- Omnicell: Omnicell is a large medication management platform serving hospitals, pharmacies, and health systems with automated dispensing, packaging, and adherence solutions. It is an incumbent benchmark for the medication management category CMT targets in specialty pharmacy and senior care settings.
- West Pharmaceutical Services: West Pharmaceutical Services supplies primary packaging, injectable delivery systems, and connected health components to pharma. It competes with CMT in the broader smart drug delivery and adherence ecosystem, particularly around pharma R&D and specialty drug delivery.
Emerging players
- QuiO Technologies: QuiO builds connected drug delivery devices (smart auto-injectors and inhaler add-ons) and a cloud platform for adherence and outcomes. It overlaps with CMT in pharma-sponsored connected-device programs and real-time dosing analytics.
- Spencer Health Solutions: Spencer Health Solutions offers a connected smart pill dispenser and patient-engagement platform aimed at seniors and chronic-disease adherence. It is a direct niche competitor to CleverCap LITE/PRO for at-home adherence and pharmaceutical patient support programs.
- emocha Health: emocha Health delivers asynchronous video-based directly observed therapy and digital adherence programs, with deep traction in public health, TB, hepatitis C, and addiction treatment. It overlaps with CMT in the addiction-treatment customer segment (e.g., Recovery Centers of America), competing for adherence contracts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
CMT social profiles
Digital presenceCMT financial estimates
Financial estimateRevenue estimate
Valuation estimate
CMT leadership team
Management profileNumber of profiles
Profiles7 records
CMT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CMT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CMT
What does CMT do?
CMT designs, manufactures, and sells the CleverCap family of cellular-connected smart pill bottle caps (CleverCap PRO and CleverCap LITE) that capture real-time medication dosing events and transmit them to a cloud-based analytics portal and companion mobile app. The integrated platform is offered to pharmaceutical manufacturers, health plans, pharmacies, and clinical trial sponsors to improve medication adherence, generate real-world evidence, and support patient engagement across chronic, specialty, and addiction-treatment therapies.
Is CMT a public or private company?
CMT is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CMT founded?
CMT was founded in 2011. It employs 1 to 10 people.
Where is CMT based?
CMT is headquartered in Miami, United States, in the North America region.
How does CMT make money?
Two revenue lines are on record. Device Sales and Software Services are the primary driver. The others are enterprise Software Platform.
Who are CMT's main competitors?
Direct peers on record are AdhereTech, Propeller Health (ResMed), etectRx and Medisafe. Broad incumbents are Aptar Pharma, Omnicell and West Pharmaceutical Services. Emerging players are QuiO Technologies, Spencer Health Solutions and emocha Health.
Does CMT have an API?
No public API is recorded for CMT.
What industry is CMT in?
CMT's product category is Medical Devices (Medication Adherence Technology). Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers). Its NAICS code is 5132 and its SIC code is 3841.